|
03.09.2024 07:00:20
|
Xlife Sciences AG Completes Strategic Review Process by Q3 2024
|
Xlife Sciences AG / Key word(s): Miscellaneous Zurich, 3rd of September 2024: Xlife Sciences AG (SIX: XLS) today announced that the Board of Directors has completed the strategic review and, as of September 2, 2024, has tasked management with implementing the process. The shareholders will be informed of the next steps by September 30, 2024, at the latest. The size and diversity of the portfolio, along with the variety of possible deal structures, significantly influenced the timeline of the process. Xlife Sciences AG extends its gratitude to all external partners for their support and valuable contributions to this important milestone. David L. Deck, Chairman of the Board of Directors of Xlife Sciences AG, commented: «The strategy identified as a result of intensive analysis and consultations represents the best option to ensure the company's long-term success and value creation. The Board is confident that this path offers the greatest potential for the future of Xlife Sciences.»
Financial calendar
Contact Xlife Sciences AG, End of Inside Information |
| Language: | English |
| Company: | Xlife Sciences AG |
| Talacker 35 | |
| 8001 Zürich | |
| Switzerland | |
| Phone: | +41 44 385 84 60 |
| E-mail: | info@xlifesciences.ch |
| Internet: | www.xlifesciences.ch |
| ISIN: | CH0461929603 |
| Valor: | A2PK6Z |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1980087 |
| End of Announcement | EQS News Service |
|
|
1980087 03-Sep-2024 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Xlife Sciences AGmehr Nachrichten
|
19.12.24 |
Schwacher Handel: SPI mittags in Rot (finanzen.at) | |
|
19.12.24 |
Xlife Sciences AG veröffentlicht ESG-Bericht 2023: Ein kontinuierliches Engagement für nachhaltige Innovation (EQS Group) | |
|
19.12.24 |
Xlife Sciences AG Publishes 2023 ESG Report: A Continued Commitment to Sustainable Innovation (EQS Group) | |
|
18.12.24 |
Angespannte Stimmung in Zürich: SPI zum Handelsende in Rot (finanzen.at) | |
|
17.12.24 |
Gute Stimmung in Zürich: SPI liegt am Dienstagnachmittag im Plus (finanzen.at) | |
|
16.12.24 |
Aufschläge in Zürich: SPI zum Start mit Kursplus (finanzen.at) | |
|
16.12.24 |
Xlife Sciences AG Announces the Intended Listing of VERAXA Biotech AG on the NASDAQ Stock Exchange in the 2025 Fiscal Year (EQS Group) | |
|
16.12.24 |
Xlife Sciences AG kündigt geplanten Börsengang der VERAXA Biotech AG an der US-amerikanischen NASDAQ im Geschäftsjahr 2025 an (EQS Group) |
Analysen zu Xlife Sciences AGmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.